106 related articles for article (PubMed ID: 26206581)
1. Lesion complexity drives the cost of superficial femoral artery endovascular interventions.
Walker KL; Nolan BW; Columbo JA; Rzucidlo EM; Goodney PP; Walsh DB; Atkinson BJ; Powell RJ
J Vasc Surg; 2015 Oct; 62(4):998-1002. PubMed ID: 26206581
[TBL] [Abstract][Full Text] [Related]
2. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
[TBL] [Abstract][Full Text] [Related]
3. Primary stenting of the superficial femoral and popliteal artery.
Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous angioplasty and stenting of the superficial femoral artery.
Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
[TBL] [Abstract][Full Text] [Related]
5. Failed superficial femoral artery intervention for advanced infrainguinal occlusive disease has a significant negative impact on limb salvage.
Al-Nouri O; Krezalek M; Hershberger R; Halandras P; Gassman A; Aulivola B; Milner R
J Vasc Surg; 2012 Jul; 56(1):106-10; discussion 110-1. PubMed ID: 22226187
[TBL] [Abstract][Full Text] [Related]
6. Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.
Dosluoglu HH; Cherr GS; Lall P; Harris LM; Dryjski ML
J Vasc Surg; 2008 Nov; 48(5):1166-74. PubMed ID: 18692357
[TBL] [Abstract][Full Text] [Related]
7. Full metal jacket stenting of the superficial femoral artery: a retrospective review.
Shah PS; Hingorani A; Ascher E; Shiferson A; Gopal K; Jung D; Marks N; Jacob T
Ann Vasc Surg; 2011 Jan; 25(1):127-31. PubMed ID: 21172588
[TBL] [Abstract][Full Text] [Related]
8. The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries.
Lee JJ; Katz SG
J Vasc Surg; 2012 Apr; 55(4):994-1000; discussion 1000. PubMed ID: 22244857
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
[TBL] [Abstract][Full Text] [Related]
10. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions.
Bakken AM; Protack CD; Saad WE; Hart JP; Rhodes JM; Waldman DL; Davies MG
Ann Vasc Surg; 2009; 23(5):560-8. PubMed ID: 19128934
[TBL] [Abstract][Full Text] [Related]
11. Stent fractures after superficial femoral artery stenting: risk factors and impact on patency.
Lin Y; Tang X; Fu W; Kovach R; George JC; Guo D
J Endovasc Ther; 2015 Jun; 22(3):319-26. PubMed ID: 25862365
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions.
Gabrielli R; Rosati MS; Vitale S; Baciarello G; Siani A; Chiappa R; Caselli G; Irace L
J Vasc Surg; 2012 Dec; 56(6):1598-605. PubMed ID: 23044257
[TBL] [Abstract][Full Text] [Related]
13. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
[TBL] [Abstract][Full Text] [Related]
14. Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease.
Malas MB; Enwerem N; Qazi U; Brown B; Schneider EB; Reifsnyder T; Freischlag JA; Perler BA
J Vasc Surg; 2014 Jan; 59(1):129-35. PubMed ID: 23891488
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of endovascular treatment for patients with TASC II D femoropopliteal occlusive disease: a single center study.
Guo X; Xue G; Huang X; Xie H; Liang W; Zhang J; Lin F; Yao T
BMC Cardiovasc Disord; 2015 May; 15():44. PubMed ID: 26022244
[TBL] [Abstract][Full Text] [Related]
16. Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention.
DeRubertis BG; Pierce M; Chaer RA; Rhee SJ; Benjeloun R; Ryer EJ; Kent C; Faries PL
J Vasc Surg; 2007 Oct; 46(4):709-16. PubMed ID: 17903651
[TBL] [Abstract][Full Text] [Related]
17. Endovascular interventions for TransAtlantic InterSociety Consensus II C and D femoropopliteal lesions.
Yin MY; Jiang ME; Huang XT; Lu M; Lu XW; Huang Y; Li WM
Chin Med J (Engl); 2013 Feb; 126(3):415-20. PubMed ID: 23422099
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.
Mohr PJ; Oyama JK; Luu JT; Stinis CT
Cardiovasc Revasc Med; 2015 Dec; 16(8):465-8. PubMed ID: 26483319
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes and predictors of iliac angioplasty with selective stenting.
Kudo T; Chandra FA; Ahn SS
J Vasc Surg; 2005 Sep; 42(3):466-75. PubMed ID: 16171589
[TBL] [Abstract][Full Text] [Related]
20. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
